RAP 0.00% 20.5¢ resapp health limited

Ann: Clinical study to develop COVID-19 screening test, page-18

  1. 362 Posts.
    lightbulb Created with Sketch. 870


    What we can reasonably assume is that a hell of a lot of research has gone on behind the scenes and that management and the Professor are very confident that they can detect Covid 19 via cough sounds. Yes it would have been ideal to have started this trial last year but here we are.

    This is huge for the future of Resapp. If the trial is a success then it gets us into the US and possibly emergency FDA approval. I think Covid 19 is going to be around in the US for a while yet and the rest of the world for that matter. It gives us a massive value add to Telehealth providers all over the world and once we're in we're in. It also creates a sense of urgency which is what we need.

    So, better late than never. This is extremely positive and I'm sure companies like Medgate will be desperate to have access to this technology once it's ready to go. A huge step in the right direction.

 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.